2026-09-19T08:20:34Zhttps://dspace.mit.edu/server/oai/request

oai:dspace.mit.edu:1721.1/443032022-01-28T18:42:35Zcom_1721.1_7582com_1721.1_7581col_1721.1_131023

Christopher L. Magee, Thomas Roemer and Don Rosenfield. Vaudant, Jérôme Leaders for Manufacturing Program. Leaders for Manufacturing Program at MIT Massachusetts Institute of Technology. Engineering Systems Division Sloan School of Management 2009-01-30T16:30:15Z 2009-01-30T16:30:15Z 2008 2008 http://hdl.handle.net/1721.1/44303 272397533 Thesis (M.B.A.)--Massachusetts Institute of Technology, Sloan School of Management; and, (S.M.)--Massachusetts Institute of Technology, Engineering Systems Division; in conjunction with the Leaders for Manufacturing Program at MIT, 2008. Includes bibliographical references (p. 79-80). With growing markets and increasing pipelines, biotechnology companies face a supply chain challenge to manufacture and distribute products using economically feasible methods that protect protein integrity. Adequate storage and shipment of drug substance is an important operation and product quality issues are dependent upon success at this stage of the manufacturing process. While cryopreservation technologies are widely in use today, they may become prohibitively expensive in the future due to increasing product volumes and high operational costs.This thesis presents an evaluation of drying technologies as an alternative to cryopreservation for recombinant protein drug substance storage and shipment. After presenting an assessment of current cryopreservation technologies, the potential of drying technologies to protect protein integrity is examined through process optimization and product characterization at laboratory scale. The economic impact of such technologies and the implications of their implementation in the manufacturing environment are discussed. Recommendations on storage technologies for drug substance are proposed based on results of the analysis. Finally, the thesis builds on this particular study to research the specifics of process development in the biopharmaceutical industry and to discuss implications for future process innovation. by Jérôme Vaudant. S.M. M.B.A. 90 p. eng Massachusetts Institute of Technology M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 Sloan School of Management. Engineering Systems Division. Leaders for Manufacturing Program. Evaluation of drying technologies for storage and shipment of recombinant protein drug substance Thesis application/pdf false Publication unknown unknown <Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="0c360b73-6048-4262-b048-18949bce01c3"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>Evaluation of drying technologies for storage and shipment of recombinant protein drug substance</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2008</PublicationDate> <Authors> <Author> <DisplayName>Vaudant, Jérôme</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>Massachusetts Institute of Technology</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>http://dspace.mit.edu/handle/1721.1/7582</License> <Keyword>Sloan School of Management.</Keyword> <Keyword>Engineering Systems Division.</Keyword> <Keyword>Leaders for Manufacturing Program.</Keyword> <Abstract>With growing markets and increasing pipelines, biotechnology companies face a supply chain challenge to manufacture and distribute products using economically feasible methods that protect protein integrity. Adequate storage and shipment of drug substance is an important operation and product quality issues are dependent upon success at this stage of the manufacturing process. While cryopreservation technologies are widely in use today, they may become prohibitively expensive in the future due to increasing product volumes and high operational costs.This thesis presents an evaluation of drying technologies as an alternative to cryopreservation for recombinant protein drug substance storage and shipment. After presenting an assessment of current cryopreservation technologies, the potential of drying technologies to protect protein integrity is examined through process optimization and product characterization at laboratory scale. The economic impact of such technologies and the implications of their implementation in the manufacturing environment are discussed. Recommendations on storage technologies for drug substance are proposed based on results of the analysis. Finally, the thesis builds on this particular study to research the specifics of process development in the biopharmaceutical industry and to discuss implications for future process innovation.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication>